Embryonic and larval zebrafish models for the discovery of new bioactive compounds against TB.

Publication date: Sep 06, 2024

TB is a world health challenge the treatment of which is impacted by the rise of drug-resistant strains. Thus, there is an urgent need for new antitubercular compounds and novel approaches to improve current TB therapy. The zebrafish animal model has become increasingly relevant as an experimental system. It has proven particularly useful during early development for aiding TB drug discovery, supporting both the discovery of new insights into mycobacterial pathogenesis and the evaluation of therapeutical toxicity and efficacy in vivo. In this review, we summarize the past two decades of zebrafish-Mycobacterium marinum research and discuss its contribution to the field of bioactive antituberculosis therapy development.

Concepts Keywords
Bioactive drug discovery
Decades Mycobacterium marinum
Discov tuberculosis
Tb zebrafish
Zebrafish

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *